NEULAND LABORATORIES
|
NEULAND LABORATORIES Last 5 Year Cashflow Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit Before Tax | ₹346 Cr | ₹401 Cr | ₹216 Cr | ₹82 Cr | ₹105 Cr |
Adjustment | ₹-12 Cr | ₹62 Cr | ₹78 Cr | ₹66 Cr | ₹40 Cr |
Changes In working Capital | ₹58 Cr | ₹-91 Cr | ₹-13 Cr | ₹-68 Cr | ₹49 Cr |
Cash Flow after changes in Working Capital | ₹392 Cr | ₹373 Cr | ₹281 Cr | ₹81 Cr | ₹195 Cr |
Cash Flow from Operating Activities | ₹317 Cr | ₹261 Cr | ₹237 Cr | ₹60 Cr | ₹189 Cr |
Cash Flow from Investing Activities | ₹-298 Cr | ₹-150 Cr | ₹-61 Cr | ₹-96 Cr | ₹-84 Cr |
Cash Flow from Financing Activities | ₹25 Cr | ₹-69 Cr | ₹-136 Cr | ₹38 Cr | ₹-114 Cr |
Net Cash Inflow / Outflow | ₹44 Cr | ₹42 Cr | ₹40 Cr | ₹2.59 Cr | ₹-8.72 Cr |
Opening Cash & Cash Equivalents | ₹88 Cr | ₹45 Cr | ₹5.09 Cr | ₹2.44 Cr | ₹11 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹0.17 Cr | ₹-0.05 Cr | ₹0.41 Cr | ₹0.06 Cr | ₹-0.05 Cr |
Closing Cash & Cash Equivalent | ₹132 Cr | ₹88 Cr | ₹45 Cr | ₹5.09 Cr | ₹2.44 Cr |
Compare Cashflow Statement of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹18,689.4 Cr | 4.4% | -7.8% | 52.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 4.4% |
-7.8% |
52.1% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses